ENDOLINK PHARMA SPÓŁKA AKCYJNA
Copy
CopyKey data
Status
KRS number
CopyREGON
CopyNIP/VAT code
CopyVAT registration date
VAT status
Bankruptcy proceedings
ENDOLINK PHARMA SPÓŁKA AKCYJNA
Contacts
Registered address
Copy
Website
HTTP://WWW.ENDOLINK.PL
D
LowReliability
D - LowIncorporation date
26/02/2021Share capital
100,000.00 PLNPrimary activity
Wholesale of pharmaceutical goods (46.46.Z - PKD 2007)Representatives
5Representatives rights
JEŻELI ZARZĄD JEST JEDNOOSOBOWY, SPÓŁKĘ REPREZENTUJE JEDYNY CZŁONEK ZARZĄDU SAMODZIELNIE. JEŻELI ZARZĄD JEST WIELOOSOBOWY, DO SKŁADANIA OŚWIADCZEŃ W IMIENIU SPÓŁKI WYMAGANE JEST WSPÓŁDZIAŁANIE DWÓCH CZŁONKÓW ZARZĄDU ALBO JEDNEGO CZŁONKA ZARZĄDU ŁĄCZNIE Z PROKURENTEM.Representatives
Business linkages
Premium users: 1.00 credit
Financial report (Okredo)
Premium users: 1.00 credit
People
Representatives
Person  | Title |
|---|---|
Piotr Paweł Cioch | Chairman of the management board |
Katarzyna Potargowicz-Cioch | Supervisory authority member |
Ireneusz Mizera | Supervisory authority member |
Bartłomiej Łukasz Świątkowski | Supervisory authority member |
Katarzyna Jolanta Gil | Supervisory authority member |
Persons with Significant Control
Persons with Significant Control
This information is available in our reports and to subscription users.Financial ratios
Net Profit (zł)
20,645Net Profit (zł)
20,645Financial report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (zł) |
| Profit before tax (zł) |
| Net Profit (zł) |
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Liquidity ratioliquidityRatio |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (zł) |
| Current liabilities (zł) |
| Non current liabilities (zł) |
| Non-current Assets (zł) |
| 2022 |
|---|
| 27,600 |
| - |
| 25,908 |
| 22.21 |
| - |
| 93.87 |
| 110,596 |
| 0 |
| 0 |
| 0 |
| 2023 |
|---|
| 28,700 |
| - |
| 25,133 |
| 22.31 |
| - |
| 87.57 |
| 135,730 |
| 0 |
| 0 |
| 0 |
| 2024 |
|---|
| 28,700 |
| - |
| 20,645 |
| 23.01 |
| - |
| 71.93 |
| 156,375 |
| 0 |
| 0 |
| 0 |
| 2024 |
|---|
| 28,700 |
| - |
| 20,645 |
| 23.01 |
| - |
| 71.93 |
| 156,375 |
| 0 |
| 0 |
| 0 |
Turnover (zł)
2024
Turnover (zł)
28,700 zł
0 % *
Profit before tax (zł)
-Net Profit (zł)
20,645 zł
-18 % *
Working capital requirement (%)
23.01 
3.14 % *
Liquidity ratio
-Net profitability (%)
71.93 %-17.86 % *
Equity (zł)
156,375 zł
15 % *
Current liabilities (zł)
0 zł- *
Non current liabilities (zł)
0 zł- *
Non-current Assets (zł)
0 zł- *
Credit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Order report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Documents
ENDOLINK PHARMA SPÓŁKA AKCYJNA Documents
Date | Description |
|---|---|
14/07/2025 | OD 01.01.2024 DO 31.12.2024 |
14/07/2024 | OD 01.01.2023 DO 31.12.2023 |
14/07/2023 | OD 01.01.2022 DO 31.12.2022 |
14/10/2022 | OD 26.02.2021 DO 31.12.2021 |